Doghri Raoudha, Aloui Asma, Berrazaga Yosra, Boujelbene Nadia, Driss Maha, Abess Imen, Fdhila Faten, Charfi Lamia, Mezlini Amel, Mrad Karima
Tunis Med. 2018 Mar;96(3):193-202.
Nephroblastoma is the most common childhood abdominal malignancy. Many studies allowed a better understanding of prognostic factors and they permitted to adapt treatment according to a risk stratification approach.
To assess the most significant factors influencing the survival of patients presenting nephroblastoma.
We conducted a retrospective study over a 10-year period between 2001 and 2010 including 42 nephrectomy specimens, assessed in the pathology department of Salah Azaiz Institute, from all children diagnosed with nephroblastoma. The tumors were subdivided into histological subtypes and histological risk groups according to the SIOP-2001 classification. Statistical analyses were performed using the Kaplan-Meir and the Cox regression methods.
The median age was 38 months. The mixed type was the most common (40% of cases). The tumors were subdivided into intermediate histological risk group (81%) and high risk group (14%). The tumors were classified as stage I (38%), stage II (24%), stage III (9%), stage IV (17%) and stage V (12%). The four-year survival rate was 83% and the event free survival rate was 85%. Age, laterality, histological risk group, tumor volume, blastema volume, stage, capsular rupture and incomplete resection had a significant impact on survival. Predictive factors of relapse were: laterality, tumor volume, blastema volume, histological risk group, stage, capsular rupture and incomplete resection.
Histological type and stage were identified as the most important prognostic factors in nephroblastoma. Further large studies are needed to establish the impact of absolute blastemal volume.
肾母细胞瘤是儿童期最常见的腹部恶性肿瘤。许多研究有助于更好地理解预后因素,并允许根据风险分层方法调整治疗方案。
评估影响肾母细胞瘤患者生存的最重要因素。
我们对2001年至2010年的10年期间进行了一项回顾性研究,纳入了42例肾切除术标本,这些标本在萨拉赫·阿扎伊兹研究所病理科进行评估,来自所有诊断为肾母细胞瘤的儿童。根据SIOP - 2001分类将肿瘤分为组织学亚型和组织学风险组。使用Kaplan - Meir和Cox回归方法进行统计分析。
中位年龄为38个月。混合型最为常见(占病例的40%)。肿瘤分为组织学中危组(81%)和高危组(14%)。肿瘤分期为I期(38%)、II期(24%)、III期(9%)、IV期(17%)和V期(12%)。四年生存率为83%,无事件生存率为85%。年龄、肿瘤位于侧别、组织学风险组、肿瘤体积、胚芽体积、分期、包膜破裂和切除不完全对生存有显著影响。复发的预测因素为:肿瘤位于侧别、肿瘤体积、胚芽体积、组织学风险组、分期、包膜破裂和切除不完全。
组织学类型和分期被确定为肾母细胞瘤最重要的预后因素。需要进一步的大型研究来确定绝对胚芽体积的影响。